Fate Therapeutics, Inc. revenue breakdown overview

Fate Therapeutics, Inc. revenue for the last year amounted to 63.53 M USD, the most of which — 63.53 M USD — came from its highest performing source at the moment, Cellular Immunotherapies, the year earlier bringing 96.30 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Fate Therapeutics, Inc. 63.53 M USD, and the year before that — 96.30 M USD.